Belongs to

• Solid Tumor Oncology Division

Types of Work

["2016"]

[[["Journal Articles",960],["Meeting Abstracts",774],["Book Sections",42],["Editorials",32],["Reviews",26],["Research Letters",15],["Guidelines",6],["Correspondences",5],["Conference Papers",4],["Miscellaneous",3],["Book Wholes",2]]]

[1869]

Popular keywords

• adult
• article
• controlled study
• female
• human
• humans
• immunotherapy
• ipilimumab
• melanoma
• priority journal

Recent Works

1. Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

   Journal Article

   Monson, K. R.; Ferguson, R.; Handzlik, J. E.; Morales, L.; Xiong, J.; Chat, V.; Dagayev, S.; Khodadadi-Jamayran, A.; Simpson, D.; Kazlow, E.; more...
   Nature Medicine (2025)

   Fulltext@MSK | Save
2. Programmed death ligand-1 PET imaging in patients with melanoma: A pilot study

   Journal Article

   Pandit-Taskar, N.; Mauguen, A.; Frosina, D.; Jungbluth, A.; Busam, K. J.; Lyashchenko, S.; Schwartz, J.; Momtaz, P.; Warner, A. B.; Smithy, J. W.; more...
   Melanoma Research (2025)

   Fulltext@MSK | Save
3. Long-term survival and biomarker analysis evaluating neoadjuvant plus adjuvant relatlimab (anti-LAG3) and nivolumab (anti-PD1) in patients with resectable melanoma

   Journal Article

   Burton, E. M.; Milton, D. R.; Tetzlaff, M. T.; Wani, K.; Ross, M. I.; Postow, M. A.; Lazcano, R.; Glitza, I. C.; Wong, M. K.; Patel, S. P.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save